Previous 10 | Next 10 |
– Live video webcast with Chairman and CEO, Dr. Gary Wilcox, on Monday, September 14 th at 3:30 PM EDT – BOTHELL, WA, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), ...
A late-stage influenza asset development is halted. The Janssen Pharmaceutical announced a strategic decision to discontinue the development of pimodivir, a Phase 3 clinical asset. The study results showed that pimodivir in combination with the standard of care (SOC) was very unlikely to demonst...
BOTHELL, WA, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, announced tod...
Gainers: VBI Vaccines (NASDAQ: VBIV ) +35% . More news on: VBI Vaccines Inc., Rekor Systems, Inc., BMC Stock Holdings, Inc., Stocks on the move, , Read more ...
Cocrystal Pharma (NASDAQ: COCP ) -25% after raising "bought deal" offering to $15M. More news on: Cocrystal Pharma, Inc., SunPower Corporation, Quidel Corporation, Stocks on the move, , Read more ...
Due to increased demand, book runner H.C. Wainwright & Co., has agreed to increase the size of the previous public offering Cocrystal Pharma's (NASDAQ: COCP ) shares of common stock and purchase ~14.3M shares (from 9.52M) at $1.05/share, for expected gross proceeds of ~$15M...
BOTHELL, WA, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, announced tod...
Cocrystal Pharma (NASDAQ: COCP ) -16.2% AH , entered into an underwriting agreement with H.C. Wainwright wherein the underwriter has agreed to purchase 9.52M shares at $1.05/share. More news on: Cocrystal Pharma, Inc., Healthcare stocks news, , Stocks on the move, Read more ....
BOTHELL, WA, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, announced tod...
FinancialBuzz.com News Commentary New York, NY (8/17/2020) – Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi and parasites, and can be transmitted by direct or indirect contact. Globally, infectious diseases such as malaria, HIV, tuberculosis...
News, Short Squeeze, Breakout and More Instantly...
Cocrystal Pharma Inc. Company Name:
COCP Stock Symbol:
NASDAQ Market:
Cocrystal Pharma Inc. Website:
BOTHELL, Wash., July 18, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) today reported favorable safety and tolerability results from the single-ascending dose (SAD) cohorts of the Phase 1 study in healthy volunteers wit...
BOTHELL, Wash., June 20, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc .’s (Nasdaq: COCP) novel, broad-spectrum antiviral CC-42344 inhibits activity in the highly pathogenic avian influenza A (H5N1) PB2 protein recently identified in infected dairy cattle, according to recently ...
Topline single ascending dose (SAD) Phase 1 results of oral CDI-988, the first potential pan-coronavirus-pan-norovirus oral antiviral, expected in the second quarter of 2024 Enrollment completed in Phase 2a influenza A human challenge study of oral CC-42344, with topline results expected ...